Catalyst
Slingshot members are tracking this event:
FDA Decision on Supplemental Application for Portola's (PTLA) Andexxa (Andexanet Alfa) Expected in May 4 2018
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PTLA |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2018
Occurred Source:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsroomArticle&ID=2347018
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Supplemental Application, Fda, Andexxa, Andexanet Alfa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery